Positive impact on lives and healthcare budgets.
Podimetrics is bringing new hope to patients, payors and providers. View our favorite highlights below or see all our clinical evidence.
Reduced Complications and Amputations
In a peer reviewed study, involving a year long foot ulcer recurrence prevention program at four outpatient centers, Podimetrics reduced:
Patient Experience and Adherence
In two different studies:
engaged at one year2
SmartMat “easy to use”3
Reduced Complications and Amputations
In a peer reviewed study, involving a year long foot ulcer recurrence prevention program at four outpatient centers, Podimetrics reduced:
52% relative risk reduction1
† Net difference was observed despite 1.6 additional podiatry outpatient visits per-participant year resulting from inflammation detected by the study device.
Cost Savings and ROI
Podimetrics calculates up to $13,000 in annual cost savings per patient4
3.6X – 5.2X
$9,800 – 14,000
Choose innovation.
Not complications and amputations.
Learn MoreWhat's new at Podimetrics?
All NewsGuest Blog from Promptly – The Psychology of Patient Trust & How Practices Can Win It
By: Anish Kapur, MD, Promptly This guest post is contributed by Promptly, a comprehensive web-based patient experience and automation suite…How Nurses Build Trust That Drives Adherence and Better Outcomes
Learn how nurses build trust with patients, and why it directly impacts adherence, outcomes, and the ability to act soonerWhat Can Patients Teach Providers About Improving DFU Care?
Patient perspectives reveal critical gaps in diabetic foot ulcer care, highlighting the need for clearer education, earlier intervention, and more…
Guest Blog from Promptly – The Psychology of Patient Trust & How Practices Can Win It
By: Anish Kapur, MD, Promptly This guest post is contributed by Promptly, a comprehensive web-based patient experience and automation suite…
1. Isaac, et al. BMJ Open Diab Res Care 2020
2. Rothenberg, et al. Fed Pract. 2020
3. Frykberg, et al. Diabetes Care 2017
4. Podimetrics Data on File
5. Assumptions based on 90 weeks of Intermountain Health claims data for 428 at-risk patients and applying results from our recent peer-reviewed study with Kaiser Permanente in the British Journal of Medicine (BMJ)